Q1 EPS Estimate for Allurion Technologies Lowered by Analyst
Allurion Technologies Inc. (NYSE:ALUR – Free Report) – Equities research analysts at Roth Capital dropped their Q1 2025 earnings estimates for shares of Allurion Technologies in a report issued on Wednesday, March 26th. Roth Capital analyst J. Wittes now forecasts that the company will post earnings of ($1.18) per share for the quarter, down from […]
More Stories
Contrasting TeraWulf (NASDAQ:WULF) and MGT Capital Investments (OTCMKTS:MGTI)
TeraWulf (NASDAQ:WULF – Get Free Report) and MGT Capital Investments (OTCMKTS:MGTI – Get Free Report) are both small-cap finance companies,...
Critical Review: MariMed (OTCMKTS:MRMD) and Juva Life (OTCMKTS:JUVAF)
MariMed (OTCMKTS:MRMD – Get Free Report) and Juva Life (OTCMKTS:JUVAF – Get Free Report) are both medical companies, but which...
Comparing Curis (NASDAQ:CRIS) and ImmunityBio (NASDAQ:IBRX)
Curis (NASDAQ:CRIS – Get Free Report) and ImmunityBio (NASDAQ:IBRX – Get Free Report) are both medical companies, but which is...
Financial Review: Takeda Pharmaceutical (NYSE:TAK) vs. Xenetic Biosciences (NASDAQ:XBIO)
Takeda Pharmaceutical (NYSE:TAK – Get Free Report) and Xenetic Biosciences (NASDAQ:XBIO – Get Free Report) are both medical companies, but...
BTC Digital (NASDAQ:BTCT) vs. Core Scientific (NASDAQ:CORZ) Head to Head Review
Core Scientific (NASDAQ:CORZ – Get Free Report) and BTC Digital (NASDAQ:BTCT – Get Free Report) are both finance companies, but...
Critical Comparison: Immatics (NASDAQ:IMTX) vs. Novonesis A/S (OTC:NVZMY)
Novonesis A/S (OTC:NVZMY – Get Free Report) and Immatics (NASDAQ:IMTX – Get Free Report) are both basic materials companies, but...